Please use this identifier to cite or link to this item:
192.168.6.56/handle/123456789/37904Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.editor | Pugsley, Michael K. | - |
| dc.date.accessioned | 2019-01-25T11:54:08Z | - |
| dc.date.available | 2019-01-25T11:54:08Z | - |
| dc.date.issued | 2003 | - |
| dc.identifier.isbn | 1-59259-404-2 | - |
| dc.identifier.isbn | 1-58829-097-2 | en_US |
| dc.identifier.uri | http://10.6.20.12:80/handle/123456789/37904 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Humana Press | en_US |
| dc.subject | Cardiovascular Agents | en_US |
| dc.subject | Drug Development | en_US |
| dc.title | Cardiac Drug Development Guide | en_US |
| dc.type | Book | en_US |
| Appears in Collections: | Pharmacy | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Mark J. Jaroszeski.pdf | 4.33 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.